Company Filing History:
Years Active: 2021-2025
Title: Adrien Nivoliez: Innovator in Probiotic Applications
Introduction
Adrien Nivoliez is a notable inventor based in Yolet, France. He has made significant contributions to the field of probiotics, particularly in the development of innovative applications that enhance their effectiveness. With a total of 4 patents to his name, Nivoliez is recognized for his pioneering work in the use of thiosulfate and mucoadhesive technologies.
Latest Patents
One of Nivoliez's latest patents is titled "Use of thiosulfate to potentiate the anti-pathogenic effect of lactobacilli." This invention focuses on utilizing thiosulfate in quantities of at least 100 mg for 10 to 10 CFU of lactobacilli bacteria. The patent also describes a pharmaceutical composition that includes at least 100 mg of thiosulfate per gram, combined with a strain of lactobacilli, aimed at treating urogenital infections such as vaginosis, candidosis, and urinary tract infections. Another significant patent is the "Mucoadhesive sustained-release vaginal tablet," which includes at least one probiotic strain compressed with an excipient that provides mucoadhesion and sustained release properties for the vaginal wall.
Career Highlights
Throughout his career, Nivoliez has worked with various companies, including Nexbiome Therapeutics and Probionov. His work has focused on enhancing the efficacy of probiotics and developing innovative delivery systems for therapeutic applications.
Collaborations
Nivoliez has collaborated with notable professionals in his field, including Claudia Thoral and Pierre Tchoreloff. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Adrien Nivoliez is a distinguished inventor whose work in probiotics has led to significant advancements in the treatment of urogenital infections. His innovative patents reflect his commitment to improving health outcomes through scientific research and development.